Conclusion: This study enhances the understanding of the relative benefits and risks associated with various VaD treatments, providing a valuable reference for clinical decision-making.
PubMed 39239652 ↗Oxiracetam
People mainly take Oxiracetam for focus, memory, energy. Based on 98 first-hand reports and 5 meta-analyses & systematic reviews in the medical literature. Ranked #136 of 1,974 overall.
Of reports that state an outcome, 65% are positive.
What Oxiracetam does, according to users
Of the people who reported each effect, the share who said it got better.
1 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found.
Conclusion: Protocol Registration: PROSPERO (ID: CRD42019117178). Available online at: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42019117178.
PubMed 31057392 ↗Conclusion: The most effective intervention for dementia available is symptomatic treatment for vascular dementia. Antipsychotic treatment for dementia alleviates cognitive dysfunction less effectively than does symptomatic treatment. Alternative therapies are also effective at present. Further research on causes and very early diagnosis of Alzheimer disease is warranted.
PubMed 29502274 ↗Conclusion: Conclusion: Our study demonstrated that ACEI inhibitors (Donepezil) and NMDA antagonists (Memantine), EGB761, and acupuncture are the ADL and BI, MoCA, and neurological function deficit medication/therapy, respectively, for patients with PSCI. Clinical Trial Registration: https://inplasy.com/inplasy-2022-11-0139/; Identifier: INPLASY2022110139.
PubMed 37693907 ↗Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
Verbatim quotes, shortened only — each links to the original discussion.
“I have phenylpiracetam, aniracetam, oxiracetam, noopept (not techincally a racetam), and good ol' piracetam.”
“Used Noopept, Oxiracetam and Phenyl, but don't really take anymore.”
“Oxiracetam/Noopept/Choline (whenever I need it. Very rarely, I don't want to build a tolerance”
“We currently only offer Pramiracetam, Sulbutiamine, Piracetam, Aniracetam, Oxiracetam, Pyritinol, Picamilon, Choline Alpha GPC, Gingko Biloba, and Bacopa Monnieri.”
“comparing the two they look identical, dissolve at the same rate, and tastes almost exactly the same (mildly bitter / sweet).”
Top discussions (5)
Other options for focus
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate